Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Encompass Health Corp Director's Dealing 2021

Feb 25, 2021

30484_dirs_2021-02-25_30639454-7eda-4f1e-96ec-96701f6ec2e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Encompass Health Corp (EHC)
CIK: 0000785161
Period of Report: 2021-02-23

Reporting Person: Tarr Mark J (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-23 Encompass Health Common Stock F 1975 $80.23 Disposed 354414 Direct
2021-02-24 Encompass Health Common Stock A 30468 Acquired 384882 Direct
2021-02-24 Encompass Health Common Stock A 12669 Acquired 397551 Direct

Footnotes

F1: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

F2: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019

F3: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.